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Mia Baudin was beginning her day by scrolling through the news. Her routine of catching up on 
global matters was always the same when she headed to work, but today the news that she 
read on her morning commute resonated with her heavily. The headline “Drug-Resistant 
Tuberculosis: A Clear and Present Danger” caught her eye. Mia continued reading. A record 
number of drug-resistant tuberculosis (TB) cases were popping up in Southeast Asia and South 
Africa. The news article stated that, in 2017 alone, drug-resistant tuberculosis was estimated to 
have caused 230,000 global deaths (Pai, 2019). Mia let out a long sigh. It felt like tuberculosis 
was a relentless disease and the fight against it was constant.  
 
Mia worked as a program officer in the Public Health Liaison Unit (PHLU) situated in the 
Migration Health Branch of Immigration, Refugees, and Citizenship Canada (IRCC). Her role 
was to communicate with provincial and territorial public health authorities (P/T PHAs) when 
foreign nationals enter Canada and record, when informed, that the foreign national had 
followed through with medical surveillance. Through her involvement with IRCC, Mia had been 
briefed on the tuberculosis situation in Canada. Although the incidence of TB here was relatively 
low, it was a large concern among the foreign-born population. Increasingly, the threat of 
multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis within this 
population was also becoming a problem. 
 
Just last week Mia had been briefed on the World Health Organization’s (WHO) goal to 
eliminate tuberculosis. The objective of their End TB Strategy was to have a 95% reduction in 
global TB incidence and associated deaths by 2035 (World Health Organization, 2015). Mia 
knew that with immigration numbers on the rise, and the threat of drug-resistant TB being a 
greater concern than ever before, the medical surveillance system needed to be running 
effectively. She wanted to do whatever she could as a program officer to make this goal of 
eliminating tuberculosis tangible while keeping up with the increased demand on the medical 
surveillance system. 
 
Mia’s position required a balancing of roles. When informed of a likely case of active 
tuberculosis where the location of the client was currently uncertain, one of Mia’s most critical 
responsibilities was to use information concerning the client in IRCC databases to determine the 
exact location of the client. This assisted in locating these individuals so that appropriate public 
health authorities could approach the client and provide appropriate treatment. In cases where 
an individual had remained untreated and was a potential public health risk, Mia had to work in 
collaboration with the P/T PHAs and the Public Health Agency of Canada (PHAC) to take 
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appropriate measures to mitigate any public health risk. Mia also had the more distinct 
responsibility of acting as a liaison and facilitating communication among foreign nationals, P/T 
PHAs, and regional health units. If a migrant arrived in Canada and reported to a public health 
unit, this reporting was then passed on to IRCC.  
 
Despite these responsibilities, Mia felt her most demanding role involved communicating with 
clients directly regarding their concerns about TB screening and surveillance. Many clients were 
not aware of the medical surveillance system and were fearful about the process. Mia guided 
these individuals through the system and alleviated their uncertainty by explaining the steps 
they had to take. This was often a lengthy and challenging process. Within the past few months, 
Mia had received a surge of emails from clients who had interpretation challenges, questions 
about reporting locations, and the cost of medical surveillance. She was finding it increasingly 
difficult to keep up with the volume of emails she was receiving. As Mia logged in to her email 
today, she was greeted with an inbox full of much of the same.  
 
She began to wonder if there was a more permanent way to address the concerns repeatedly 
brought forward. Migrants needed answers immediately and Mia wanted to ensure she could 
guide them through their requirement for public health surveillance inside Canada, but Mia also 
knew that she couldn’t keep up with this demand alone. Her capacity within her role was already 
being stretched. Something more needed to be done to meet the current and future demands 
caused by population growth related to immigration. What was it within the medical surveillance 
system that was acting as a barrier to clients? Was the medical surveillance system not 
sufficiently client friendly? Perhaps identifying this was the first step. 
 
BACKGROUND 
As a program officer working in the PHLU, Mia had gained an in-depth understanding of the 
medical screening and surveillance processes. She reflected on the knowledge she had 
accumulated along the way. 
 
Medical Surveillance and Immigration, Refugees, and Citizenship Canada 
IRCC is the branch of the federal government responsible for regulating the entry of foreign 
nationals to Canada. This includes assessing the health of immigrants and refugees to Canada 
in order to identify certain infectious diseases of public health concern. The identification of 
these diseases then allows for effective facilitation of treatment.   
 
Within IRCC, the Migration Health Branch oversees the health screening process which 
includes the Immigration Medical Examination (IME) and assessment of the IME which 
determines which clients can enter as well as the subsequent Immigrant Medial Surveillance 
(IMS) processes. The primary focus of the IME is to detect active cases of tuberculosis in the 
foreign national population, as active pulmonary TB renders a person medically inadmissible to 
Canada (Immigration, Refugees and Citizenship Canada – IRCC, 2014) until they are 
successfully treated. The primary focus of the IMS is to have clients at a risk of developing 
active TB report to P/T PHAs so they can be monitored and offered treatment if they become an 
active TB case (IRCC, 2014). 
 
Immigration Medical Examination 
Any person applying for permanent residency must undergo the IME. In addition, foreign 
nationals must undergo an IME even if they are temporary residents but intend to work in an 
occupation that could bring them in close contact with people, and in which the protection of 
public health is essential (IRCCa, 2019). There are many other applicants who are required to 
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undergo a medical exam, including some work permit candidates under International 
Experience Canada, certain health care students who are work-permit exempt, and people 
arriving as refugees (IRCCa, 2019). The IME must be conducted by a physician who is 
approved to conduct these types of exams. These physicians are known as panel physicians 
and they are located across the globe (IRCCb, 2019). The IME guidelines and components are 
outlined by IRCC. They include: 
 
 Documentation of medical history 
 Complete physical examination 
 Chest x-ray and laboratory testing  
 
Immigration Medical Surveillance  
Foreign nationals found to have a condition that is a public health concern, such as inactive TB, 
must undergo IMS. Clients must proceed to a medical follow-up where further monitoring and 
appropriate treatment are determined. If a foreign national presents with inactive pulmonary 
tuberculosis, they must report to a public health authority within 90 days of entering Canada. 
However, if a client is identified as a more urgent case through the presentation of complex non-
infectious active pulmonary tuberculosis, they must report within seven days (IRCC, 2014).  
Once this initial assessment is completed, a client is noted from an immigration point of view as 
being in compliance and the medical terms and conditions are lifted from their visa application. 
 
Individuals who have active TB are inadmissible to Canada until they have undergone treatment 
for tuberculosis and have demonstrated proof of this. IRCC verifies this by collecting chest x-
rays and other laboratory results from a respiratory specialist who confirms the client’s 
diagnosis, the client’s drug regimen/course of treatment, and their disease prognosis. 
Individuals who have active tuberculosis are also assessed for their antibiotic resistance to 
determine whether they present with multidrug-resistant or extremely drug-resistant TB. 
 
The Medical Surveillance Pathway 
Once a foreign national arrives at a Port of Entry in Canada, in many cases, a Canadian border 
security agent completes a medical surveillance undertaking form (IMM0535) and sends it to the 
PHLU. This form optimally contains the foreign national’s Canadian address and contact 
information. 
 
When the PHLU receives this information, they reference the province/territory indicated on the 
form and inform the designated jurisdiction of the individual’s arrival to Canada. This starts the 
medical surveillance process. The province then initiates contact with a regional health unit or 
tuberculosis clinic that follows up with the client, does a risk assessment and directs them 
through the process of diagnostic testing and TB care if required. With this initial contact, the 
province/territory informs PHLU that a client is in compliance. 
 
The British North America Act of 1867 (Health Canada, 2019) dictates that provinces/territories 
are responsible for healthcare provision. This means that implementation of TB control 
programs takes place at the provincial/territorial level and there are variations of these control 
programs depending on the responsible jurisdiction. Although there is a single published 
Canadian TB standard, each P/T determines how medical surveillance is carried out in their 
jurisdiction, including which IME documentation is required. These jurisdictional authorities are 
also able to establish how TB care is set up, with certain provinces having designated 
tuberculosis clinics and others relying on community health centers and public health units to 
facilitate care for the migrant population.  
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This lack of uniformity can create challenges for foreign nationals undergoing medical 
surveillance. Many migrants who move to different provinces might have to repeat their medical 
surveillance in order to meet compliance requirements in their new province. Clients are 
barraged with different types of insurance coverages, multiple costs associated with diagnostic 
tests, and disparate wait times for surveillance appointments depending on the province in 
which they reside. This makes creating a seamless and uniform country-wide medical 
surveillance system an even greater challenge. 
 
The Global Tuberculosis Burden 
Although Mia had been briefed on the purpose of medical screening and surveillance when she 
joined the Migration Health Branch, she initially had a limited understanding about tuberculosis 
itself. Dr. Greg Walkins, the Migration Health Branch’s medical officer, had delivered a lecture 
on tuberculosis within Mia’s first few weeks at the job, and this had helped her learn more about 
the disease.  
 
Tuberculosis is a disease that has impacted humanity for thousands of years. It was only on 
March 24, 1882 when Dr. Robert Koch isolated Mycobacterium tuberculosis and determined it 
was the causal bacteria behind the disease (Floyd et al., 2018). At the time of this discovery, TB 
was responsible for devastating Europe, with mortality rates exceeding 100 per 100,000 people 
per year (Floyd et al., 2018). Although large strides have been made in tackling TB through 
effective drug treatment research, TB remains the top global cause of death from an infectious 
agent (Floyd et al., 2018). It is found in every country in the world, with drug-resistant TB being 
found in every country in which it has been measured (Floyd et al., 2018). 
 
Tuberculosis is first treated via a six-month combination regimen of first-line drugs. These drugs 
include isoniazid, rifampicin, ethambutol, and pyrazinamide (Floyd et al., 2018). If an individual 
has multi-drug resistant TB (both rifampicin and multidrug resistant), they typically undergo 
treatment with second-line drugs that are more toxic and expensive. This regimen can last 
anywhere from nine to twenty-four months in duration. To date, the only licensed vaccine 
available to decrease the likelihood of developing certain severe forms of TB is the bacille 
Calmette-Guerin vaccine. This vaccine is most effective at preventing tuberculosis in infants and 
young children, with its protection in older children and adults ranging from 0% to 80% (Floyd et 
al., 2018).  
 
With tuberculosis being responsible for 1.5 million deaths globally in 2018 (World Health 
Organization, 2019), it is critical that there are structures in place to limit the public health risk of 
TB transmission in Canada. Although the foreign-born population represents approximately one 
fifth of the total Canadian population, it constitutes a large majority of those enduring the 
greatest disease burden (PHAC, 2019). In 2017, the foreign-born population accounted for 
71.8% of active TB cases in Canada (LaFreniere et al., 2019), demonstrating a disproportionate 
impact of the disease on this population. Furthermore, people who become permanent residents 
and may also have latent (inactive) TB are at a greater risk of developing active TB due to 
previous exposure, difficulty in accessing health services, and food and housing insecurity 
(LaFreniere et al., 2019). Appropriately directing individuals through treatment and surveillance 
is meant as an introduction to health care within Canada and as a method to ensure the health 
and safety of people arriving to the country as well as the local population. 
 
The World Health Organization has implemented the End TB Strategy to reduce the global 
incidence of tuberculosis. The goal is to reduce the global incidence of the disease from the rate 
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of 110 per 100,000 in 2015 to 100 per 100,000 or less by 2035 (WHO, 2019). Data from 2017 
demonstrated that there were 1,796 cases of active TB in Canada, amounting to an incidence of 
4.9/100,000 (LaFreniere et al., 2019). 
 
SPECIFIC AREA OF INTEREST 
Ensuring Compliance with Medical Surveillance 
The proportion of the foreign-born population in Canada is continuing to rise, with immigration 
rates slowly approaching levels last seen in 1913. The 2016 Canadian census indicated that 
7,540,830 people had come to Canada through the immigration process, which represented 
21.9% of Canada’s population at the time (Statistics Canada, 2017). Ensuring the positive 
health status of these is an important objective for IRCC. 
 
Although the incidence of TB in Canada is low within the general population, this contrasts with 
the incidence in nations from which foreign nationals arrive. The World Health Organization’s 
Global Tuberculosis Report (2019) states that most TB cases occur in Southeast Asia (44%) 
and Africa (25%). The report also reveals that the 30 highest TB burden countries constitute 
87% of all estimated incident cases worldwide (World Health Organization, 2019). India, China, 
Indonesia, the Philippines, Pakistan, Nigeria, Bangladesh, and South Africa have the largest TB 
burden (Exhibit 1). Asia continues to remain the top source continent from which recent 
immigrants arrive to Canada, with 2016 data revealing that 61.8% of newcomers arriving here 
between 2011 and 2016 were from this geographic location. 
 
The challenge that exists for IRCC, and particularly for the Migration Health Branch in improving 
the prevention and management of tuberculosis within the foreign national population in Canada 
is the appropriate integration of the IMS procedures with provincial/territorial TB control 
programs. The other challenge is, although immigration numbers are increasing, the resources 
allocated to effectively guide foreign nationals through the medical screening and surveillance 
processes are not. This creates an additional burden on the key stakeholders and the current 
medical surveillance system in ensuring screening and surveillance programs are effective. 
Transition to more effective and efficient IME and IMS procedures will be challenging. 
 
The PHLU is a critical point of contact for many newcomers to Canada who must undergo 
medical surveillance. The PHLU is responsible for creating a supportive environment for foreign 
nationals who may have recently been diagnosed with active or latent TB. Because many 
individuals are unaware of their health status until they undergo the IME, it is essential that the 
PHLU be involved in creating lines of communication that is not stigmatizing to immigrants. 
Medical screening and surveillance should be viewed as a stepping stone in achieving 
integration into Canada and its health care system with the eventual step of taking on 
citizenship. Negative attitudes and fear about the surveillance process can further impact the 
number of people who are able or willing to comply with this requirement. This is why the 
messaging around medical surveillance and the manner in which surveillance is conducted are 
critical to its success. 
 
Back to the Tasks at Hand 
Mia stared at her computer feeling slightly dejected. It was only the middle of the afternoon and 
the emails flooding her inbox showed no signs of slowing down. There were many client 
concerns and varied inquiries related to a variety of stressors. Many new immigrants were not 
sure if they required medical surveillance or if they were responsible for contacting their local 
public health units. Some clients wondered what the examinations would cost. Others did not 
Is it too Late to Re-evaluate? Creating Client-centered Changes within Canada’s 
Medical Surveillance System 
 
116 
know what to do when they relocated to different provinces, and many immigrants had 
difficulties understanding the terminology used by IRCC. 
 
Mia was concerned that, at this rate, the PHLU would not be able to manage the task of guiding 
clients through their concerns while fulfilling its other roles and responsibilities. She realized that 
if the volume of migrants continued to increase, there would be even more client concerns to 
address in the near future. Mia also recognized that as challenging as it was keeping up with 
client correspondence, behind these emails were people who had valid concerns about the 
medical requirements pertaining to their visa applications. Mia needed to find a solution to the 
repeat client concerns that required her attention. She wanted to identify a way to change 
certain barriers within the medical surveillance system to make it more client centric, but she 
didn’t know where to start. She first had to analyze at what points stressors were occurring for 
clients. Only after understanding this could changes then be proposed. 
 
SPECIFIC PROBLEM OF DECISION 
In the upcoming weeks, the Migration Health Branch’s strategic plan was going to be discussed. 
This strategic plan focused on targets and goals for the next four years. If proposing to make the 
medical screening and surveillance system more client-centric was a priority, this was the 
opportune time to add this proposal to the agenda. Mia flipped open her calendar to next week’s 
team meeting.  
 
The weekly meeting held on Thursdays would be the ideal time to propose the notion of tackling 
client challenges within the medical surveillance system. With her colleagues’ support, Mia felt 
she could take the first essential step to evaluating the barriers to client compliance. Without 
doing this, program changes could not be proposed and implemented. Mia knew she needed 
more people on board. Taking on an initiative of this scale with limited resources would be 
challenging but possible if it was well structured. Mia did not want to start this project without 
being able to truly assess client needs and deficiencies within the program. Without doing her 
due diligence, this evaluation would not lead to any long-term change.  
 
Mia wondered how, as a mid-level employee of the PHLU, she could best take on this initiative. 
How could she perform an effective evaluation that incorporated the perspectives of the various 
stakeholders involved? This would mean taking note of perspectives from the Migration Health 
Branch, the PHLU, the P/T PHAs, and those working regionally at the frontline of client care. 
She began jotting down all the stakeholders involved along the client’s journey through medical 
surveillance. To understand the deficiencies in the surveillance program, she needed the 
stakeholders’ perspectives as well as the clients’ testimonials about their experiences. 
 
Mia knew that the team did not have additional funds to spend on hiring someone to put 
together an evaluation of client challenges within the medical surveillance system. This was her 
shot at creating a valuable resource that could then be used to implement positive change at the 
client level. She reminded herself that behind every file was a story. This was an opportunity to 
capture it and make an impact by representing it fairly. 
 
CONCLUSION 
Mia began thinking about the process. She had just under a week to develop an outline of what 
was needed to create a comprehensive evaluation of the medical surveillance system in regard 
to client-centred deficiencies. She began by writing down the input she required from 
stakeholders, the resources needed, and her timeline to make this assessment happen. Next 
week when she walked into the weekly team meeting, she would bring forward her plan to begin 
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addressing client challenges within the medical surveillance system. The process would not be 
easy, but she knew her Master of Public Health education, public health training, and 
experience would help her draw on appropriate resources and create an initiative grounded in 
its structure. This would hopefully be enough to demonstrate the importance of this idea and 
have it incorporated into the strategic plan. Mia let out another deep breath and eagerly got to 
work. She knew she was adding one larger task to her list, but she couldn’t wait to see the 
results of her ambition. 
  
Is it too Late to Re-evaluate? Creating Client-centered Changes within Canada’s 








Source: World Health Organization, 2019. 
  
Is it too Late to Re-evaluate? Creating Client-centered Changes within Canada’s 









2. Immigration, Refugees, and Citizenship Canada. (2019a). Who must submit to an 






3. Immigration, Refugees, and Citizenship Canada. (2019b). Who may perform an 




4. Floyd, K., Glaziou, P., Zumla, A., & Raviglione, M. (2018). The global tuberculosis 
epidemic and progress in care, prevention, and research: An overview in year 3 of the 
End TB era. Lancet Respiratory Medicine, 6(4), 299–314. doi:10.1016/S2213-
2600(18)30057-2  
5. Health Canada. (2019). Canada’s Health Care System. Retrieved from 
https://www.canada.ca/en/health-canada/services/health-care-system/reports-
publications/health-care-system/canada.html#a3 
6.  LaFreniere, M., Hussain, H., He, N., & McGuire, M. (2019). Tuberculosis in Canada. 
Canadian Communicable Disease Report, 45(2/3), 68-74. Doi:10.14745/ccdr.v45i2a04 
7. Pai, M. (2019). Drug-resistant TB: A clear and present danger. Retrieved from 
https://www.forbes.com/sites/madhukarpai/2019/05/07/a-clear-and-present-
danger/#b71b6ee6b1a8  




9. Statistics Canada. (2017). Immigration and ethnocultural diversity: Key results from the 
2016 census. Retrieved from https://www150.statcan.gc.ca/n1/daily-
quotidien/171025/dq171025b-eng.htm?indid=14428-1&indgeo=0  
10. World Health Organization. (2015). The End TB Strategy. Retrieved from 
https://www.who.int/tb/End_TB_brochure.pdf 













Is it too Late to Re-evaluate? Creating Client-centered 
Changes within Canada’s Medical Surveillance System 
 
 
Fatema Jamaly, BA, RDH, MPH (Class of 2019)  
Monique St-Laurent, (Assistant Director, Immigration, Refugees and Citizenship Canada, Public 
Health Liaison Unit, Migrant Health Branch) 
Amardeep Thind, MD, PhD (Professor, Western University)  
 
BACKGROUND 
Mia is a program officer in the Public Health Liaison Unit at Immigration, Refugees, and 
Citizenship Canada’s Migration Health Branch. Mia works with her team to oversee medical 
surveillance notifications related to tuberculosis. Mia and her team identify migrants arriving to 
Canada who require tuberculosis testing and care, and connect them with the appropriate 
Provincial/Territorial Public Health Authority in the province or territory they want to reside in. 
Lately, Mia has noticed that the number and type of client concerns filling up her email inbox are 
increasing. These client concerns range from knowledge, language, and interpretation barriers, 
to difficulties understanding where to report for medical surveillance. Mia wants to conduct a 
program evaluation to determine exactly where client barriers exist within the medical 
surveillance system. She wants to use this information to suggest transformation to areas that 
require change.  
 
OBJECTIVES 
1. Use an understanding of disease incidence, prevalence, and surveillance to influence the 
development of programs or interventions for targeting and eliminating disease 
transmission.   
2. Select quantitative and qualitative data collection methods that are appropriate for 
conducting a program evaluation. Determine which stakeholders and resources are required 
to do this. 
3. Discuss the means to achieve health equity for foreign nationals by specifically looking at 
how immigrants undergo medical surveillance in Canada.  




1. How does the Public Health Liaison Unit help facilitate medical surveillance? 
2. What is the main challenge identified by the protagonist Mia in the case? 
3. What are the challenges endured by immigrants who arrive in a new country? How might 
this impact their ability to complete medical surveillance? 
4. What factors need to be considered when conducting a program evaluation?  
5. How can successful program evaluations be used to transform programs and interventions? 
 
KEYWORDS 
Client-centered program evaluation; foreign nationals; medical surveillance; tuberculosis. 
